BackBaird Equity Opportunity Fund - Investor Class Overview

Baird Equity Opportunity Fund - Investor Class Total Liabilities

Track Baird Equity Opportunity Fund - Investor Class's total liabilities ($450M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$452.08M
↓ 26.82% YoYΔ $-165.70M vs prior year quarter

Peer trimmed avg / median

Loading

Baird Equity Opportunity Fund - Investor Class Total Liabilities History

Loading

Baird Equity Opportunity Fund - Investor Class vs. peers: Total Liabilities Comparison

Loading

Baird Equity Opportunity Fund - Investor Class Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Baird Equity Opportunity Fund - Investor Class (BSVSX) FAQ

As of the most recent data (December 2023), BSVSX shows a total liabilities of $450M. That compares with $620M in the prior-year period — down 26.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BSVSX's total liabilities is now $450M (was $620M) — a 26.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Baird Equity Opportunity Fund - Investor Class is outperforming or lagging.

Tracking BSVSX's total liabilities over time shows whether Baird Equity Opportunity Fund - Investor Class is scaling, shrinking, or reshaping that part of the business. The current reading is $450M That compares with $620M in the prior-year period — down 26.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Baird Equity Opportunity Fund - Investor Class's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $450M) with ownership activity and broader fundamentals.